Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

E-Health-Supported Preoperative Education

10 de mayo de 2026 actualizado por: Sema Nur YAMAN ÇELİK, Dokuz Eylul University

EVALUATION OF THE EFFECTIVENESS OF PRE-OPERATIVE EDUCATION PROVIDED TO PATIENTS UNDERGOING CHEST SURGERY VIA AN E-HEALTH APPLICATION: A RANDOMIZED CONTROLLED STUDY

In the context of patient education, the integration of mobile applications-an e-health modality-among healthcare professionals and patients has garnered significant attention alongside technological advancements. Mobile applications offer distinct advantages, notably the vast global population capable of accessing and utilizing these digital tools. A study evaluating the impact of mobile applications on the recovery of patients undergoing ambulatory surgery demonstrated that the quality of recovery was superior in the intervention group. In research investigating mobile application-based education following breast cancer surgery, significant improvements were observed in pain levels, affected shoulder functions, and anxiety levels within the intervention group .

Among patients undergoing cardiac surgery, 98% of those who received education via a mobile application reported that the application was beneficial to their recovery process . Furthermore, in a study involving a mobile application for patients undergoing heart valve surgery, the intervention group exhibited significantly lower probabilities of hospitalization, emergency department visits, and complications . An integrative review of mobile applications in the health education of surgical patients noted that while research has involved bariatric, orthopedic, colorectal, mastectomy, urological, and neurological surgical patients, there is an emphasized need for further nursing research utilizing emerging communication technologies.

To date, no studies evaluating the effectiveness of preoperative education delivered via mobile application for patients undergoing thoracic surgery have been identified. Initiating preoperative preparation for patients scheduled for thoracic surgery is anticipated to positively influence postoperative recovery and quality of life, highlighting the necessity for research in this domain.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Actual)

128

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Patients aged 18 years and older
  • Patients with full spatial and temporal orientation
  • Patients without significant hearing or vision impairments
  • Patients with the ability to read and write
  • Patients scheduled for elective thoracic surgery due to a lung mass
  • Patients who voluntarily agree to participate and provide written informed consent
  • Patients who own and can operate a smartphone

Exclusion Criteria:

  • Patients scheduled for emergency thoracic surgery
  • Patients with physical limitations that prevent mobilization or participation in study tests
  • Patients with cognitive impairments (as they may fail to provide accurate data via the app)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: E-health preoperative education
E-health education group
Preoperative education provided to patients via a mobile e-health application including video-based and written educational content developed based on current thoracic surgery guidelines.
Sin intervención: Control
Standard care group

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Health-Related Quality of Life (EQ-5D-5L)
Periodo de tiempo: 10 days before surgery and 10 days after surgery.
Health-related quality of life will be assessed using the Turkish version of the EQ-5D-5L scale. The scale consists of two parts: a descriptive system covering five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and the EQ Visual Analogue Scale (EQ VAS). The descriptive system provides a health state profile across five levels for each dimension. The EQ VAS is a vertical 0-100 scale where 0 represents "the worst health you can imagine" and 100 represents "the best health you can imagine." Assessments will be conducted 10 days before surgery and 10 days after surgery. The study will utilize the official Turkish translation provided by the EuroQol Research Foundation.
10 days before surgery and 10 days after surgery.
Postoperative Physical Capacity (6-Minute Walk Test)
Periodo de tiempo: Day 3 post-operatively
Postoperative physical capacity will be evaluated using the 6-Minute Walk Test (6MWT). This test measures the maximum distance (in meters) a patient can walk at a self-selected pace on a flat surface in 6 minutes. The mobilization levels and total walking time (in minutes) will also be recorded to compare the physical recovery and functional capacity between the intervention group (mobile app-based training) and the control group (standard training).
Day 3 post-operatively
Postoperative Pulmonary Complications
Periodo de tiempo: Day 3 post-operatively
Evaluation of respiratory complications based on clinical signs and laboratory findings. A complication is defined as meeting two or more criteria, including respiratory distress, abnormal breath sounds, and abnormal white blood cell counts (leukopenia or leukocytosis) according to standard clinical reference ranges.
Day 3 post-operatively
State Anxiety Inventory (STAI-I)
Periodo de tiempo: 10 days before surgery and Day 3 post-operatively
The State Anxiety Inventory (STAI-I) is a 20-item self-report scale that measures current anxiety. Scores range from 20 to 80, with higher scores indicating higher anxiety levels. It uses a 4-point Likert-type scale for each item.
10 days before surgery and Day 3 post-operatively
Length of Hospital Stay
Periodo de tiempo: From the date of surgery until the date of hospital discharge
The length of hospital stay (measured in days) will be recorded and compared between the intervention and control groups. The duration will be calculated from the day of surgery until the day of discharge. Data will be obtained from the patients' medical records after discharge to evaluate whether mobile application-based training has an impact on the timing of clinical recovery and hospital resource utilization.
From the date of surgery until the date of hospital discharge

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

18 de octubre de 2024

Finalización primaria (Actual)

22 de septiembre de 2025

Finalización del estudio (Actual)

22 de septiembre de 2025

Fechas de registro del estudio

Enviado por primera vez

22 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de mayo de 2026

Publicado por primera vez (Actual)

14 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

14 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de mayo de 2026

Última verificación

1 de octubre de 2025

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

De-identified individual participant data (IPD) including demographic characteristics, outcome measures, and questionnaire responses collected during the study will be shared. All data will be anonymized and will not contain any personally identifiable information.

Marco de tiempo para compartir IPD

IPD will be available upon reasonable request to the corresponding investigator following publication of the study results. Data will be shared for scientific research purposes only, after approval of a proposal and with a signed data use agreement.

Criterios de acceso compartido de IPD

De-identified individual participant data (IPD) and supporting documents will be available to researchers for scientific research purposes. Access will be granted upon reasonable written request to the corresponding investigator, subject to approval of a research proposal and signing of a data use agreement. Shared materials will be limited to anonymized datasets and relevant study documents (e.g., study protocol, statistical analysis plan). Data will be provided through a secure electronic system.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF
  • CÓDIGO_ANALÍTICO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir